Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 7.112
Filtrer
1.
Environ Sci Pollut Res Int ; 31(43): 55280-55300, 2024 Sep.
Article de Anglais | MEDLINE | ID: mdl-39227535

RÉSUMÉ

The present study describes a set of methodological procedures (seldom applied together), including (i) development of an alternative adsorbent derived from abundant low-cost plant biomass; (ii) use of simple low-cost biomass modification techniques based on physical processing and chemical activation; (iii) design of experiments (DoE) applied to optimize the removal of a pharmaceutical contaminant from water; (iv) at environmentally relevant concentrations, (v) that due to initial low concentrations required determination by ultra-performance liquid phase chromatography coupled to mass spectrometry (UPLC-MS/MS). A central composite rotational design (CCRD) was employed to investigate the performance of vegetable sponge biomass (Luffa cylindrica), physically processed (crushing and sieving) and chemically activated with phosphoric acid, in the adsorption of the antibiotic trimethoprim (TMP) from water. The optimized model identified pH as the most significant variable, with maximum drug removal (91.1 ± 5.7%) achieved at pH 7.5, a temperature of 22.5 °C, and an adsorbent/adsorbate ratio of 18.6 mg µg-1. The adsorption mechanisms and surface properties of the adsorbent were examined through characterization techniques such as scanning electron microscopy (SEM), point of zero charge (pHpzc) measurement, thermogravimetric analysis (TGA), specific surface area, and Fourier-transform infrared spectroscopy (FTIR). The best kinetic fit was obtained by the Avrami fractional-order model. The hypothesis of a hybrid behavior of the adsorbent was suggested by the equilibrium results presented by the Langmuir and Freundlich models and reinforced by the Redlich-Peterson model, which achieved the best fit (R2 = 0.982). The thermodynamic study indicated an exothermic, spontaneous, and favorable process. The maximum adsorption capacity of the material was 2.32 × 102 µg g-1 at an equilibrium time of 120 min. Finally, a sustainable and promising adsorbent for the polishing of aqueous matrices contaminated by contaminants of emerging concern (CECs) at environmentally relevant concentrations is available for future investigations.


Sujet(s)
Biomasse , Luffa , Triméthoprime , Polluants chimiques de l'eau , Purification de l'eau , Luffa/composition chimique , Adsorption , Polluants chimiques de l'eau/composition chimique , Triméthoprime/composition chimique , Purification de l'eau/méthodes , Eau/composition chimique , Cinétique
2.
J Hazard Mater ; 479: 135721, 2024 Nov 05.
Article de Anglais | MEDLINE | ID: mdl-39255667

RÉSUMÉ

Reducing antibiotic levels in soil ecosystems is vital to curb the dissemination of antimicrobial resistance genes (ARGs) and mitigate global health threats. However, gaps persist in understanding how antibiotic resistome can be suppressed during antibiotic degradation. Herein, we investigate the efficacy of a biochar biofilm incorporating antibiotics-degrading bacterial strain (Arthrobacter sp. D2) to mitigate antibiotic resistome in non-manured and manure-amended soils with sulfadiazine (SDZ) and trimethoprim (TMP) contamination. Results show that biofilm enhanced SDZ degradation by 83.0% within three days and increased TMP attenuation by 55.4% over 60 days in non-manured soils. In the non-manured black soil, the relative abundance of ARGs increased initially after biofilm inoculation. However, by day 30, it decreased by 20.5% compared to the controls. Moreover, after 7 days, biofilm reduced TMP by 38.5% in manured soils and decreased the total ARG abundance by 19.0%. Thus, while SDZ degradation did not increase sulfonamide resistance genes, TMP dissipation led to a proliferation of insertion sequences and related TMP resistance genes. This study underscores the importance of antibiotic degradation in reducing related ARGs while cautioning against the potential proliferation and various ARGs transfer by resistant microorganisms.


Sujet(s)
Antibactériens , Biofilms , Fumier , Microbiologie du sol , Polluants du sol , Sulfadiazine , Triméthoprime , Sulfadiazine/pharmacologie , Biofilms/effets des médicaments et des substances chimiques , Triméthoprime/pharmacologie , Polluants du sol/toxicité , Antibactériens/pharmacologie , Fumier/microbiologie , Arthrobacter/génétique , Arthrobacter/effets des médicaments et des substances chimiques , Arthrobacter/métabolisme , Charbon de bois , Gènes bactériens , Résistance bactérienne aux médicaments/génétique , Résistance microbienne aux médicaments/génétique
3.
Nat Commun ; 15(1): 7536, 2024 Aug 30.
Article de Anglais | MEDLINE | ID: mdl-39214976

RÉSUMÉ

Nucleocytoplasmic large DNA viruses (NCLDVs; also called giant viruses), constituting the phylum Nucleocytoviricota, can infect a wide range of eukaryotes and exchange genetic material with not only their hosts but also prokaryotes and phages. A few NCLDVs were reported to encode genes conferring resistance to beta­lactam, trimethoprim, or pyrimethamine, suggesting that they are potential vehicles for the transmission of antibiotic resistance genes (ARGs) in the biome. However, the incidence of ARGs across the phylum Nucleocytoviricota, their evolutionary characteristics, their dissemination potential, and their association with virulence factors remain unexplored. Here, we systematically investigated ARGs of 1416 NCLDV genomes including those of almost all currently available cultured isolates and high-quality metagenome-assembled genomes from diverse habitats across the globe. We reveal that 39.5% of them carry ARGs, which is approximately 37 times higher than that for phage genomes. A total of 12 ARG types are encoded by NCLDVs. Phylogenies of the three most abundant NCLDV-encoded ARGs hint that NCLDVs acquire ARGs from not only eukaryotes but also prokaryotes and phages. Two NCLDV-encoded trimethoprim resistance genes are demonstrated to confer trimethoprim resistance in Escherichia coli. The presence of ARGs in NCLDV genomes is significantly correlated with mobile genetic elements and virulence factors.


Sujet(s)
Génome viral , Virus géants , Phylogenèse , Virus géants/génétique , Génome viral/génétique , Résistance microbienne aux médicaments/génétique , Bactériophages/génétique , Bactériophages/isolement et purification , Antibactériens/pharmacologie , Métagénome/génétique , Transfert horizontal de gène , Triméthoprime/pharmacologie , Résistance bactérienne aux médicaments/génétique
4.
mBio ; 15(9): e0136024, 2024 Sep 11.
Article de Anglais | MEDLINE | ID: mdl-39120145

RÉSUMÉ

Antimicrobial resistance (AMR) is a public health threat worldwide. Next-generation sequencing (NGS) has opened unprecedented opportunities to accelerate AMR mechanism discovery and diagnostics. Here, we present an integrative approach to investigate trimethoprim (TMP) resistance in the key pathogen Streptococcus pneumoniae. We explored a collection of 662 S. pneumoniae genomes by conducting a genome-wide association study (GWAS), followed by functional validation using resistance reconstruction experiments, combined with machine learning (ML) approaches to predict TMP minimum inhibitory concentration (MIC). Our study showed that multiple additive mutations in the folA and sulA loci are responsible for TMP non-susceptibility in S. pneumoniae and can be used as key features to build ML models for digital MIC prediction, reaching an average accuracy within ±1 twofold dilution factor of 86.3%. Our roadmap of in silico analysis-wet-lab validation-diagnostic tool building could be adapted to explore AMR in other combinations of bacteria-antibiotic. IMPORTANCE: In the age of next-generation sequencing (NGS), while data-driven methods such as genome-wide association study (GWAS) and machine learning (ML) excel at finding patterns, functional validation can be challenging due to the high numbers of candidate variants. We designed an integrative approach combining a GWAS on S. pneumoniae clinical isolates, followed by whole-genome transformation coupled with NGS to functionally characterize a large set of GWAS candidates. Our study validated several phenotypic folA mutations beyond the standard Ile100Leu mutation, and showed that the overexpression of the sulA locus produces trimethoprim (TMP) resistance in Streptococcus pneumoniae. These validated loci, when used to build ML models, were found to be the best inputs for predicting TMP minimal inhibitory concentrations. Integrative approaches can bridge the genotype-phenotype gap by biological insights that can be incorporated in ML models for accurate prediction of drug susceptibility.


Sujet(s)
Antibactériens , Étude d'association pangénomique , Apprentissage machine , Tests de sensibilité microbienne , Streptococcus pneumoniae , Résistance au triméthoprime , Triméthoprime , Streptococcus pneumoniae/génétique , Streptococcus pneumoniae/effets des médicaments et des substances chimiques , Triméthoprime/pharmacologie , Antibactériens/pharmacologie , Humains , Résistance au triméthoprime/génétique , Génome bactérien , Séquençage nucléotidique à haut débit , Infections à pneumocoques/microbiologie , Mutation
5.
J Environ Manage ; 368: 122090, 2024 Sep.
Article de Anglais | MEDLINE | ID: mdl-39126848

RÉSUMÉ

The saline wastewater produced in industrial activities and seawater use would flow into wastewater treatment plants and affect the characteristic of extracellular polymeric substance (EPS) of activated sludge, which could potentially impact the removal of antibiotics via adsorption. Nonetheless, the effect of salinity on trimethoprim adsorption by activated sludge extracellular polymeric substances at trace concentration and the underlying mechanism remain largely unknown. In this study, the effect of salinity on the adsorption removal of a typical antibiotic, i.e., trimethoprim (TMP) at trace concentration (25.0 µg/L) was evaluated. The results showed the content of EPS was decreased significantly from 56.36 to 21.70 mg/g VSS when the salinity was increased from 0 to 10 g/L. Protein fractions occupied the predominant component of EPS, whose concentration was decreased from 38.17 to 12.83 mg/g VSS. The equilibrium adsorption capacity of activated sludge for TMP was decreased by 49.70% (from 4.97 to 2.50 µg/g VSS). The fluorescence quenching results indicated the fluorescence intensity of tryptophan-like substances was decreased by 30% and the adsorption sites of EPS were decreased from 0.51 to 0.21 when the salinity was increased. The infrared spectrum and XPS results showed that the nitrogen-containing groups from protein were decreased significantly. The circular dichroic analysis showed α helix structure of protein in EPS was decreased with the increase of salinity, which was responsible for the decrease of adsorption capacity for TMP.


Sujet(s)
Matrice de substances polymériques extracellulaires , Salinité , Eaux d'égout , Triméthoprime , Eaux d'égout/composition chimique , Adsorption , Triméthoprime/composition chimique , Matrice de substances polymériques extracellulaires/composition chimique , Matrice de substances polymériques extracellulaires/métabolisme , Eaux usées/composition chimique , Polluants chimiques de l'eau/composition chimique
6.
Environ Sci Pollut Res Int ; 31(39): 52233-52252, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-39138731

RÉSUMÉ

Sulfamethoxazole (SMX) and trimethoprim (TRIM) are two of the most used antibiotics in the last 50 years, to prevent and treat bacterial infections; however, the available literature about toxicity to non-target organisms is quite discrepant and incomplete. This study aims to assess the SMX and TRIM ecotoxicological effects in standard species: Aliivibrio fischeri (bioluminescence inhibition), Escherichia coli ATCC 25922 (growth inhibition), Lemna minor (growth inhibition and biochemical biomarkers), Daphnia magna (immobilization/mortality, life history traits, and biochemical biomarkers), and Danio rerio (survival, hatching, abnormalities, and biochemical biomarkers). The species tested showed different acute sensitivities to SMX (A. fischeri < D. magna < E. coli < L. minor) and TRIM (L. minor < A. fischeri < D. magna < E. coli). Overall, TRIM reveals less toxicity than SMX, except for E. coli (Ecotoxicological approach based on Antimicrobial Susceptibility Testing - EcoAST procedure). Both antibiotics affect individually (e.g., growth and survival) and sub-individually (e.g., antioxidant defenses) L. minor, D. magna, and D. rerio. This study allowed us to generate relevant data and fill gaps in the literature regarding the effects of SMX and TRIM in aquatic organisms. The here-obtained results can be used to (i) complete and re-evaluate the Safety Data Sheet to improve the assessment of environmental safety and management of national and international entities; (ii) clarify the environmental risks of these antibiotics in aquatic ecosystems reinforcing the inclusion in the 4th Watch List of priority substances to be monitored in whole inland waters by the Water Framework Directive; and (iii) combat the development of antimicrobial resistance, as well as supporting the definition of environmental measurements in the context of European One Health Action Plan. However, it is essential to continue studying these antibiotics to better understand their toxicity at ecologically relevant concentrations and their long-term effects under different climatic change scenarios.


Sujet(s)
Écotoxicologie , Sulfaméthoxazole , Triméthoprime , Danio zébré , Triméthoprime/toxicité , Sulfaméthoxazole/toxicité , Animaux , Aliivibrio fischeri/effets des médicaments et des substances chimiques , Escherichia coli/effets des médicaments et des substances chimiques , Poissons , Polluants chimiques de l'eau/toxicité , Antibactériens/toxicité , Daphnia/effets des médicaments et des substances chimiques , Bactéries/effets des médicaments et des substances chimiques
7.
Poult Sci ; 103(11): 104200, 2024 Nov.
Article de Anglais | MEDLINE | ID: mdl-39208484

RÉSUMÉ

Sulfonamides (S) are old bacteriostatic antibiotics which are widely prescribed in combination with trimethoprim (TMP) for the treatment of various diseases in food-producing animals such as poultry. Nowadays, the 1:5 dose ratio of TMP/S used in broilers is a direct transposition of the ratio determined in Human decades ago for TMP/sulfamethoxazole (SMX), aiming to obtain a supposed synergistic plasma concentration ratio of 1:19. However, major pharmacokinetics (PK) differences exist according to the sulfonamide used in the combination. Here, we generated new PK data in broilers after a cross-over design with IV and the oral administration of 2 major sulfonamides, sulfadiazine (SDZ) and SMX, in combination with TMP, and analyzed the data via a population pharmacokinetic (popPK) modeling approach. Results showed that TMP has a greater plasma to tissue distribution than both sulfonamides with a higher volume of distribution (0.51 L/kg for SDZ, 0.62 L/kg for SMX and 3.14 L/kg for TMP). SMX has the highest elimination half-life (2.83 h) followed by SDZ and TMP (2.01 h and 1.49 h, respectively). The oral bioavailability of the 3 molecules was approximately 100%. Bodyweight could explain some of the inter-individual variability in the volume of distribution of SDZ and SMX and the clearance of SDZ and TMP, as heavier broilers have higher typical values. Monte Carlo simulations of a large virtual broiler population (n = 1,000) showed that the targeted plasma ratio of TMP:S of 1:19 was rarely or never reached at the individual level for both combinations at the marketed doses and greatly varies over time and between individuals, questioning the relevance of the 1:5 dose ratio for current formulations of TMP/S.


Sujet(s)
Poulets , Sulfadiazine , Association triméthoprime-sulfaméthoxazole , Triméthoprime , Animaux , Poulets/métabolisme , Sulfadiazine/pharmacocinétique , Sulfadiazine/administration et posologie , Triméthoprime/pharmacocinétique , Triméthoprime/administration et posologie , Association triméthoprime-sulfaméthoxazole/pharmacocinétique , Association triméthoprime-sulfaméthoxazole/administration et posologie , Administration par voie orale , Association médicamenteuse , Antibactériens/pharmacocinétique , Antibactériens/administration et posologie , Études croisées , Mâle , Modèles biologiques , Période , Femelle ,
8.
Environ Pollut ; 360: 124588, 2024 Nov 01.
Article de Anglais | MEDLINE | ID: mdl-39033844

RÉSUMÉ

Antibiotics present in human urine pose significant challenges for the use of urine-based fertilizers in agriculture. This study introduces a novel two-stage approach utilizing distinct biochar types to mitigate this concern. Initially, a modified biochar selectively adsorbed azithromycin (AZ), ciprofloxacin (CPX), sulfamethoxazole (SMX), trimethoprim (TMP), and tetracycline (TC) from human urine. Subsequently, a separate pristine biochar was employed to capture nutrients. Biochar, derived from sewage sludge and pyrolyzed at 550 and 700 °C, was modified using dimethyl sulfoxide, deep eutectic solvent, and ionic liquid to enhance antibiotic removal in the first stage. The modifications introduced hydrophilic functional groups (-OH/-COOH), which favor antibiotic adsorption. Adsorption kinetics followed the pseudo-second-order model, with the Langmuir isotherm model best describing the adsorption data. The maximum adsorption capacities for AZ, CPX, SMX, TMP, and TC after the modification were 196.08, 263.16, 81.30, 370.37, and 833.33 µg/g, respectively. Pristine biochar exhibited a superior ammonia adsorption capacity compared to the modified biochar. Hydrogen bonding, electrostatic attraction, and chemisorption drove antibiotic adsorption on the modified biochar. Regeneration efficiency declined due to solvent accumulation and potential byproduct formation on the biochar surface (<30% removal capacity after three cycles). This study presents innovative biochar modification strategies for selective antibiotic adsorption, laying the groundwork for environmentally friendly urine-based fertilizers in agriculture.


Sujet(s)
Antibactériens , Charbon de bois , Solvants eutectiques profonds , Diméthylsulfoxyde , Liquides ioniques , Charbon de bois/composition chimique , Adsorption , Humains , Liquides ioniques/composition chimique , Antibactériens/urine , Antibactériens/composition chimique , Diméthylsulfoxyde/composition chimique , Solvants eutectiques profonds/composition chimique , Sulfaméthoxazole/urine , Sulfaméthoxazole/composition chimique , Polluants chimiques de l'eau/composition chimique , Triméthoprime/urine , Triméthoprime/composition chimique , Ciprofloxacine/urine , Ciprofloxacine/composition chimique , Tétracycline/composition chimique , Tétracycline/urine , Azithromycine/composition chimique , Azithromycine/urine , Engrais , Cinétique
9.
Int J Pharm ; 661: 124416, 2024 Aug 15.
Article de Anglais | MEDLINE | ID: mdl-38964490

RÉSUMÉ

In this work, multicomponent trimethoprim-based pharmaceutical solid systems were developed by mechanochemistry, using coformers from the GRAS list and other active pharmaceutical ingredients. The choice of coformers took into account their potential to increase the aqueous solubility/dissolution rate of TMP or its antibacterial activity. All the binary systems were characterized by thermal analysis, powder X-ray diffraction and infrared spectroscopy, and 3 equimolar systems with FTIR pointing to salts, and 4 eutectic mixtures were identified. The intrinsic dissolution rate of TMP in combination with nicotinic acid (a salt) and with paracetamol (eutectic mixture) were 25% and 5% higher than for pure TMP, respectively. For both Gram-positive and -negative strains, the antibacterial activity of TMP with some of the coformers was improved, since the dosage used was lower than the TMP control. A significant increase in antibacterial activity against E. coli was found for the eutectic mixture with curcumin, with the best results being obtained for the eutectic and equimolar mixtures with ciprofloxacin. Combining trimethoprim with coformers offers an interesting alternative to using trimethoprim alone: multicomponent forms with enhanced TMP dissolution rates were identified, as well as combinations showing enhanced antibacterial activity relatively to the pure drug.


Sujet(s)
Antibactériens , Escherichia coli , Solubilité , Triméthoprime , Triméthoprime/composition chimique , Triméthoprime/pharmacologie , Antibactériens/pharmacologie , Antibactériens/composition chimique , Escherichia coli/effets des médicaments et des substances chimiques , Tests de sensibilité microbienne , Acétaminophène/composition chimique , Acétaminophène/pharmacologie , Curcumine/composition chimique , Curcumine/pharmacologie , Diffraction des rayons X/méthodes , Chimie pharmaceutique/méthodes , Ciprofloxacine/composition chimique , Ciprofloxacine/pharmacologie , Libération de médicament
10.
J Environ Manage ; 366: 121868, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-39032257

RÉSUMÉ

The Fenton reaction is recognized as an effective technique for degrading persistent organic pollutants, such as the emerging pollutant trimethoprim (TMP). Recently, due to the excellent reducibility of active hydrogen ([H]), Pd-H2 has been preferred for Fenton-like reactions and the specific H2 activation of Pd-based catalysts. Herein, a heterogeneous Fenton catalyst named the hydrogen-accelerated oxygen reduction Fenton (MHORF@UiO-66(Zr)) system was prepared through the strategy of building ships in the bottle. The [H] has been used for the acceleration of the reduction of Fe(III) and self-generate H2O2. The systematic characterization demonstrated that the nano Pd0 particle was highly dispersed into the UiO-66(Zr). The results found that 20 mg L-1 of TMP was thoroughly degraded within 90 min in the MHORF@UiO-66(Zr) system under conditions of initial pH 3, 30 mL min-1 H2, 2 g L-1 Pd@UiO-66(Zr) and 25 µM Fe2+. The hydroxyl radical as well as the singlet oxygen were evidenced to be the main reactive oxygen species by scavenging experiments and electron spin resonance. In addition, both reducing Fe(III) and self-generating H2O2 could be achieved due to the strong metal-support interaction (SMSI) between the nano Pd0 particles and UiO-66(Zr) confirmed by the correlation results of XPS and calculation of density functional theory. Finally, the working mechanism of the MHORF@UiO-66(Zr) system and the possible degradation pathway of the TMP have been proposed. The novel system exhibited excellent reusability and stability after six cyclic reaction processes.


Sujet(s)
Peroxyde d'hydrogène , Triméthoprime , Peroxyde d'hydrogène/composition chimique , Triméthoprime/composition chimique , Catalyse , Fer/composition chimique , Palladium/composition chimique , Oxydoréduction
11.
Environ Pollut ; 356: 124308, 2024 Sep 01.
Article de Anglais | MEDLINE | ID: mdl-38844040

RÉSUMÉ

Antibiotics, frequently detected in aquatic ecosystems, can negatively impact the health of resident organisms. Although the study on the possible effects of antibiotics on these organisms has been increasing, there is still little information available on the molecular effects on exposed non-target organisms. In our study we used a label free proteomic approach and sea bream, Sparus aurata, to evaluate the effects of exposure to environmentally relevant concentrations of the antibiotic compounds ciprofloxacin (CIP), sulfadiazine (SULF) and trimethoprim (TRIM) produced at the protein level. Individuals of sea bream were exposed to single compounds at 5.2 ± 2.1 µg L-1 of CIP, 3.8 ± 2.7 µg L-1 of SULF and 25.7 ± 10.8 µg L-1 of TRIM for 21 days. After exposure, the number of differentially expressed proteins in the liver was 39, 73 and 4 for CIP, SULF and TRIM respectively. In the brain, there was no alteration of proteins after CIP and TRIM treatment, while 9 proteins were impacted after SULF treatment. The differentially expressed proteins were involved in cellular biological, metabolic, developmental, growth and biological regulatory processes. Overall, our study evidences the vulnerability of Sparus aurata, after exposure to environmentally relevant concentrations of the major antibiotics CIP, SULF and TRIM and that their chronic exposure could lead to a stress situation, altering the proteomic profile of key organs such as brain and liver.


Sujet(s)
Antibactériens , Encéphale , Ciprofloxacine , Foie , Protéomique , Dorade , Sulfadiazine , Triméthoprime , Polluants chimiques de l'eau , Animaux , Dorade/métabolisme , Foie/métabolisme , Foie/effets des médicaments et des substances chimiques , Polluants chimiques de l'eau/toxicité , Encéphale/métabolisme , Encéphale/effets des médicaments et des substances chimiques
12.
Ecotoxicol Environ Saf ; 279: 116510, 2024 Jul 01.
Article de Anglais | MEDLINE | ID: mdl-38810284

RÉSUMÉ

Microplastics and organic micropollutants are two emerging contaminants that interact with each other in environmental and engineered systems. Sorption of organic micropollutants, such as pharmaceuticals, pesticides and industrial compounds, to microplastics can modify their bioavailability and biodegradation. The present study investigated the capacity of ultra-high density polyethylene particles (125 µm in diameter), before and after aging, to sorb 21 organic micropollutants at different environmentally relevant concentration. Furthermore, the biodegradation of these organic micropollutants by a biofilm microbial community growing on the microplastic surface was compared with the biodegradation by a microbial community originating from activated sludge. Among all tested organic micropollutants, propranolol (70%), trimethoprim (25%) and sotalol (15%) were sorbed in the presence of polyethylene particles. Growth of a biofilm on the polyethylene particles had a beneficial effect on the sorption of bromoxynil, caffeine and chloridazon and on the biodegradation of irbesartan, atenolol and benzotriazole. On the other hand, the biofilm limited the sorption of trimethoprim, propranolol, sotalol and benzotriazole and the biodegradation of 2,4-D. These results showed that ultra-high density polyethylene particles can affect both in a positive and negative way for the abiotic and biotic removal of organic micropollutants in wastewater. This project highlights the need for further investigation regarding the interaction between microplastics and organic micropollutants in the aquatic environment.


Sujet(s)
Dépollution biologique de l'environnement , Biofilms , Microplastiques , Polyéthylène , Propranolol , Polluants chimiques de l'eau , Polluants chimiques de l'eau/analyse , Polyéthylène/composition chimique , Adsorption , Triméthoprime , Aténolol , Triazoles/composition chimique , Eaux d'égout/composition chimique , Eaux d'égout/microbiologie
13.
Aquat Toxicol ; 271: 106937, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38728928

RÉSUMÉ

In aquaculture around the world, sulfamonomethoxine (SMM), a long-acting antibiotic that harms microalgae, is widely employed in combination with trimethoprim (TMP), a synergist. However, their combined toxicity to microalgae under long-term exposures at environmentally relevant concentrations remains poorly understood. Therefore, we studied the effects of SMM single-exposures and co-exposures (SMM:TMP=5:1) at concentrations of 5 µg/L and 500 µg/L on Chlorella pyrenoidosa within one aquacultural drainage cycle (15 days). Photosynthetic activity and N assimilating enzyme activities were employed to evaluate microalgal nutrient assimilation. Oxidative stress and flow cytometry analysis for microalgal proliferation and death jointly revealed mechanisms of inhibition and subsequent self-adaptation. Results showed that exposures at 5 µg/L significantly inhibited microalgal nutrient assimilation and induced oxidative stress on day 7, with a recovery to levels comparable to the control by day 15. This self-adaptation and over 95 % removal of antibiotics jointly contributed to promoting microalgal growth and proliferation while reducing membrane-damaged cells. Under 500 µg/L SMM single-exposure, microalgae self-adapted to interferences on nutrient assimilation, maintaining unaffected growth and proliferation. However, over 60 % of SMM remained, leading to sustained oxidative stress and apoptosis. Remarkably, under 500 µg/L SMM-TMP co-exposure, the synergistic toxicity of SMM and TMP significantly impaired microalgal nutrient assimilation, reducing the degradation efficiency of SMM to about 20 %. Consequently, microalgal growth and proliferation were markedly inhibited, with rates of 9.15 % and 17.7 %, respectively, and a 1.36-fold increase in the proportion of cells with damaged membranes was observed. Sustained and severe oxidative stress was identified as the primary cause of these adverse effects. These findings shed light on the potential impacts of antibiotic mixtures at environmental concentrations on microalgae, facilitating responsible evaluation of the ecological risks of antibiotics in aquaculture ponds.


Sujet(s)
Microalgues , Stress oxydatif , Sulfamonométhoxine , Triméthoprime , Polluants chimiques de l'eau , Triméthoprime/toxicité , Polluants chimiques de l'eau/toxicité , Microalgues/effets des médicaments et des substances chimiques , Stress oxydatif/effets des médicaments et des substances chimiques , Sulfamonométhoxine/toxicité , Chlorella/effets des médicaments et des substances chimiques , Chlorella/métabolisme , Chlorella/croissance et développement , Nutriments/métabolisme , Photosynthèse/effets des médicaments et des substances chimiques , Antibactériens/toxicité
14.
Ir J Med Sci ; 193(4): 1891-1900, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38565823

RÉSUMÉ

BACKGROUND: Escherichia coli is the predominant urinary pathogen in children. Irish and international studies have demonstrated increasing antimicrobial resistance (AMR) to antibiotics such as co-amoxiclav. AIMS: We aimed to (1) examine the AMR patterns of paediatric urinary E. coli isolates, from both hospital and community sources, over a 10-year period; (2) assess the effectiveness of Children's Health Ireland (CHI) antimicrobial guidance given local susceptibility data; and (3) review the clinical management of an admitted patient sub-set over a 6-year period. METHODS: Pure growth of urinary E. coli from patients aged ≤ 14 from 2012 to 2021 were analysed for AMR. Differences in susceptibility rates were assessed. A retrospective chart review conducted on inpatients aged ≥ 2 months to ≤ 14 years, 2016-2021. RESULTS: E. coli accounted for 70.8% of likely significant positive pure growth cultures (9314 isolates). Susceptibility to co-amoxiclav significantly increased over time, from 66.7% to 80.4% (2016-2021, p < 0.001). Nitrofurantoin and cefalexin had significantly higher susceptibility rates than trimethoprim (< 70% annually). 85.1% of isolates were susceptible to the combination of co-amoxiclav and gentamicin, recommended for those > 2months and systemically unwell. The additional gain in empiric susceptibility provided by gentamicin above that provided by co-amoxiclav alone has fallen from 16.4% to 6.7% (2016-2021). The 222 clinical cases reviewed showed improved antimicrobial guideline compliance over time. CONCLUSIONS: This study provides important regional AMR data. Co-amoxiclav susceptibility increased significantly over time, contrasting with previous studies. This was temporally associated with stewardship measures reducing co-amoxiclav prescribing. Decreasing utility of gentamicin supports recent CHI guideline updates reducing gentamicin use.


Sujet(s)
Antibactériens , Infections à Escherichia coli , Escherichia coli , Infections urinaires , Humains , Infections urinaires/traitement médicamenteux , Infections urinaires/microbiologie , Études rétrospectives , Infections à Escherichia coli/traitement médicamenteux , Enfant , Nourrisson , Antibactériens/usage thérapeutique , Escherichia coli/effets des médicaments et des substances chimiques , Escherichia coli/isolement et purification , Enfant d'âge préscolaire , Femelle , Mâle , Adolescent , Tests de sensibilité microbienne , Association amoxicilline-clavulanate de potassium/usage thérapeutique , Résistance bactérienne aux médicaments , Irlande/épidémiologie , Nitrofurantoïne/usage thérapeutique , Triméthoprime/usage thérapeutique
15.
Vet Res ; 55(1): 48, 2024 Apr 09.
Article de Anglais | MEDLINE | ID: mdl-38594744

RÉSUMÉ

Actinobacillus pleuropneumoniae (APP) is a bacterium frequently associated with porcine pleuropneumonia. The acute form of the disease is highly contagious and often fatal, resulting in significant economic losses for pig farmers. Serotype diversity and antimicrobial resistance (AMR) of APP strains circulating in north Italian farms from 2015 to 2022 were evaluated retrospectively to investigate APP epidemiology in the area. A total of 572 strains isolated from outbreaks occurring in 337 different swine farms were analysed. The majority of isolates belonged to serotypes 9/11 (39.2%) and 2 (28.1%) and serotype diversity increased during the study period, up to nine different serotypes isolated in 2022. The most common resistances were against tetracycline (53% of isolates) and ampicillin (33%), followed by enrofloxacin, florfenicol and trimethoprim/sulfamethoxazole (23% each). Multidrug resistance (MDR) was common, with a third of isolates showing resistance to more than three antimicrobial classes. Resistance to the different classes and MDR varied significantly depending on the serotype. In particular, the widespread serotype 9/11 was strongly associated with florfenicol and enrofloxacin resistance and showed the highest proportion of MDR isolates. Serotype 5, although less common, showed instead a concerning proportion of trimethoprim/sulfamethoxazole resistance. Our results highlight how the typing of circulating serotypes and the analysis of their antimicrobial susceptibility profile are crucial to effectively manage APP infection and improve antimicrobial stewardship.


Sujet(s)
Infections à Actinobacillus , Actinobacillus pleuropneumoniae , Pleuropneumonie , Maladies des porcs , Thiamphénicol/analogues et dérivés , Suidae , Animaux , Sérogroupe , Tests de sensibilité microbienne/médecine vétérinaire , Enrofloxacine , Fermes , Études rétrospectives , Pleuropneumonie/épidémiologie , Pleuropneumonie/médecine vétérinaire , Pleuropneumonie/microbiologie , Antibactériens/pharmacologie , Sulfaméthoxazole/pharmacologie , Triméthoprime/pharmacologie , Italie/épidémiologie , Maladies des porcs/épidémiologie , Maladies des porcs/microbiologie , Infections à Actinobacillus/épidémiologie , Infections à Actinobacillus/médecine vétérinaire , Infections à Actinobacillus/microbiologie , Sérotypie/médecine vétérinaire
16.
J Hazard Mater ; 471: 134287, 2024 Jun 05.
Article de Anglais | MEDLINE | ID: mdl-38653132

RÉSUMÉ

Antibiotics can generally be detected in the water-sediment systems of lakes. However, research on the migration and transformation of antibiotics in water-sediment systems based on the influences of light and wind waves is minimal. To address this research gap, we investigated the specific impacts of light and wind waves on the migration and transformation of three antibiotics, norfloxacin (NOR), trimethoprim (TMP), and sulfamethoxazole (SMX), under simulated light and wind waves disturbance conditions in a water-sediment system from Taihu Lake, China. In the overlying water, NOR was removed the fastest, followed by TMP and SMX. Compared to the no wind waves groups, the disturbance of big wind waves reduced the proportion of antibiotics in the overlying water. The contributions of light and wind waves to TMP and SMX degradation were greater than those of microbial degradation. However, the non-biological and biological contributions of NOR to degradation were almost equal. Wind waves had a significant impact on the microbial community changes in the sediment, especially in Methylophylaceae. These results verified the influence of light and wind waves on the migration and transformation of antibiotics, and provide assistance for the risk of antibiotic occurrence in water and sediments.


Sujet(s)
Antibactériens , Sédiments géologiques , Sulfaméthoxazole , Polluants chimiques de l'eau , Vent , Antibactériens/composition chimique , Polluants chimiques de l'eau/composition chimique , Polluants chimiques de l'eau/analyse , Polluants chimiques de l'eau/effets des radiations , Sulfaméthoxazole/composition chimique , Sédiments géologiques/composition chimique , Norfloxacine/composition chimique , Triméthoprime/composition chimique , Lacs/composition chimique , Chine , Lumière
17.
Int J Biol Macromol ; 268(Pt 2): 131947, 2024 May.
Article de Anglais | MEDLINE | ID: mdl-38685542

RÉSUMÉ

Trimethoprim (TMP), an antibiotic contaminant, can be effectively removed from water by using the innovative magnetic metal-organic framework (MOF) composite sponge Fe3O4@Rh-MOF@PIC, which is shown in this study. The composite is made up of magnetite (Fe3O4) nanoparticles and a rhodium MOF embedded in a poly(itaconic acid) grafted chitosan matrix. The structure and characteristics of the synthesized material were confirmed by thorough characterization employing SEM, FTIR, XPS, XRD, and BET techniques. Notably, the composite shows a high magnetic saturation of 64 emu g-1, which makes magnetic separation easier, according to vibrating sample magnetometry. Moreover, BET analysis revealed that the Fe3O4@Rh-MOF@PIC sponge had an incredibly high surface area of 1236.48 m2/g. Its outstanding efficacy was confirmed by batch adsorption tests, which produced a maximum adsorption capacity of 391.9 mg/g for the elimination of TMP. Due to its high porosity, magnetic characteristics, and superior trimethoprim uptake, this magnetic MOF composite sponge is a promising adsorbent for effective removal of antibiotics from contaminated water sources. An adsorption energy of 24.5 kJ/mol was found by batch investigations on the Fe3O4@Rh-MOF@PIC composite sponge for trimethoprim (TMP) adsorption. The fact that this value was up 8 kJ/mol suggests that the main mechanism controlling TMP absorption onto the sponge adsorbent is chemisorption. Chemisorption requires creating strong chemical interactions between adsorbate and adsorbent surface groups, unlike weaker physisorption. The magnetic composite sponge exhibited strong removal capabilities and high adsorption capacities for the antibiotic pollutant. The Fe3O4@Rh-MOF@PIC composite sponge also showed magnetism, which allowed for easy magnetic separation after adsorption. Over the course of 6 cycles, it showed outstanding reusability, and XRD confirmed that its composition was stable. The high surface area MOF's pore filling, hydrogen bonding, π-π stacking, and electrostatic interactions were the main trimethoprim adsorption mechanisms. This magnetic composite is feasible and effective for removing antibiotics from water because of its separability, reusability, and synergistic adsorption mechanisms via electrostatics, H-bonding, and π-interactions. The adsorption results were optimized using Box Behnken-design (BBD).


Sujet(s)
Chitosane , Réseaux organométalliques , Triméthoprime , Eaux usées , Polluants chimiques de l'eau , Purification de l'eau , Chitosane/composition chimique , Réseaux organométalliques/composition chimique , Triméthoprime/composition chimique , Polluants chimiques de l'eau/composition chimique , Polluants chimiques de l'eau/isolement et purification , Adsorption , Purification de l'eau/méthodes , Eaux usées/composition chimique , Thermodynamique , Cinétique , Succinates
18.
J Agric Food Chem ; 72(12): 6772-6780, 2024 Mar 27.
Article de Anglais | MEDLINE | ID: mdl-38478886

RÉSUMÉ

Trimethoprim (TMP), functioning as a synergistic antibacterial agent, is utilized in diagnosing and treating diseases affecting livestock and poultry. Human consumption of the medication indirectly may lead to its drug accumulation in the body and increase drug resistance due to its prolonged metabolic duration in livestock and poultry, presenting significant health hazards. Most reported immunoassay techniques, such as ELISA and immunochromatographic assay (ICA), find it challenging to achieve the dual advantages of high sensitivity, simplicity of operation, and a wide detection range. Consequently, an open droplet microchannel-based magnetosensor for immunofluorometric assay (OMM-IFA) of trimethoprim was created, featuring a gel imager to provide a signal output derived from the highly specific antibody (Ab) targeting trimethoprim. The method exhibited high sensitivity in chicken and pork samples, with LODs of 0.300 and 0.017 ng/mL, respectively, and a wide linear range, covering trimethoprim's total maximum residue limits (MRLs). Additionally, the spiked recoveries in chicken and pork specimens varied between 81.6% and 107.9%, maintaining an acceptable variation coefficient below 15%, aligning well with the findings from the ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) technique. The developed method achieved a much wider linear range of about 5 orders of magnitude of 10-2-103 levels with grayscale signals as the output signal, which exhibited high sensitivity, excellent applicability and simple operability based on magnetic automation.


Sujet(s)
, Viande rouge , Animaux , Humains , Suidae , Triméthoprime , Chromatographie en phase liquide , Poulets , Spectrométrie de masse en tandem/méthodes , Volaille , Dosage fluoroimmunologique , Chromatographie en phase liquide à haute performance/méthodes
19.
Cornea ; 43(8): 1044-1048, 2024 Aug 01.
Article de Anglais | MEDLINE | ID: mdl-38537125

RÉSUMÉ

PURPOSE: Antimicrobial resistance is a global health threat, compounded by the reduction in the discovery of new antibiotics. A repurposed drugs-based approach could provide a viable alternative for the treatment of multidrug-resistant (MDR) bacterial infections. In this study, we sought to evaluate the in vitro efficacy of a novel drug combination, polymyxin B/trimethoprim (PT) + rifampin on MDR isolates from patients with bacterial keratitis in India. METHODS: Forty-three isolates, which included 20 Staphylococcus aureus , 19 Pseudomonas aeruginosa , 3 Pseudomonas stutzeri , and 1 Acinetobacter baumannii , were evaluated for their antibiotic resistance by minimum inhibitory concentration (MIC). Fractional Inhibitory Concentration Index (FICI) testing was performed to measure the antimicrobial impact of PT + rifampin in combination. RESULTS: Among S. aureus isolates, 100% were resistant to at least 1 antibiotic class, 12 (60%) were MDR, and 14 (70%) were classified as methicillin-resistant. Among the gram-negative isolates, >90% were classified as MDR. Fractional Inhibitory Concentration (FIC) testing revealed that PT + rifampin was effective in completely inhibiting growth of all isolates while also displaying additive or synergistic activity in approximately 70% of the strains. Mean FICI values were 0.753 ± 0.311 and 0.791 ± 0.369 for S. aureus and gram-negative isolates, respectively, and a >2-fold reduction in MIC was measured for both PT and rifampin when tested in combination versus alone. CONCLUSIONS: Our data demonstrate the ability of PT + rifampin to eliminate all isolates tested, even those conferring MDR, highlighting the promise of this drug combination for the treatment of bacterial keratitis.


Sujet(s)
Antibactériens , Association médicamenteuse , Multirésistance bactérienne aux médicaments , Infections bactériennes de l'oeil , Tests de sensibilité microbienne , Polymyxine B , Rifampicine , Humains , Antibactériens/pharmacologie , Antibactériens/usage thérapeutique , Infections bactériennes de l'oeil/microbiologie , Infections bactériennes de l'oeil/traitement médicamenteux , Rifampicine/pharmacologie , Rifampicine/usage thérapeutique , Polymyxine B/pharmacologie , Triméthoprime/pharmacologie , Triméthoprime/usage thérapeutique , Association de médicaments
20.
J Am Vet Med Assoc ; 262(6): 825-833, 2024 Jun 01.
Article de Anglais | MEDLINE | ID: mdl-38479105

RÉSUMÉ

Trimethoprim-sulfonamide (TMPS) combinations are widely used to treat a range of infectious diseases in horses, but some equine practitioners are reluctant to use them for treatment of both neonatal and older foals. Considering the emergence of increased antimicrobial resistance, the use of protected antimicrobials commonly prescribed to foals should be avoided and alternative first-line therapy considered, where appropriate. This review examines the characteristics and pharmacokinetics of TMPS and its suitability for treatment of foals. Data regarding dosage and route of administration are reported on the basis of recent publications in foals. The review intends to share significant information about the common infections that are most likely responsive to TMPS treatment in foals and, as such, where TMPS might be considered a suitable first-line therapeutic option.


Sujet(s)
Maladies des chevaux , Triméthoprime , Animaux , Equus caballus , Maladies des chevaux/traitement médicamenteux , Triméthoprime/usage thérapeutique , Triméthoprime/administration et posologie , Antibactériens/usage thérapeutique , Antibactériens/administration et posologie , Antibactériens/pharmacocinétique , Sulfonamides/usage thérapeutique , Sulfonamides/administration et posologie , Animaux nouveau-nés , Anti-infectieux/usage thérapeutique , Anti-infectieux/administration et posologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE